About us Contacts Interactions: 118 620
Drug search by name

Bismuth subcitrate potassium, metronidazole, and tetracycline and Blood dyscrasias

Result of checking the interaction of drug Bismuth subcitrate potassium, metronidazole, and tetracycline and disease Blood dyscrasias for safety when used together.

Check result:
Bismuth subcitrate potassium, metronidazole, and tetracycline <> Blood dyscrasias
Relevance: 23.07.2019 Reviewer: Shkutko P.M., M.D., in

When checking interaction based on authoritative sources Drugs.com, Rxlist.com, Webmd.com, Medscape.com there are contraindications or side effects that may cause harm or increase the negative effect from drug use in presence of concomitant diseases.

Consumer:

The use of nitroimidazoles (e.g., metronidazole, tinidazole) has rarely been associated with hematologic adverse effects such as mild, transient leukopenia, thrombocytopenia, and bone marrow aplasia. The manufacturers recommend that therapy with nitroimidazoles be administered cautiously in patients with evidence of or a history of blood dyscrasias, and that total and differential leukocyte counts be performed before and after treatment with these drugs, particularly in patients receiving repeated courses of therapy.

References:
  • White CM, Price JJ, Hunt KM "Bone marrow aplasia associated with metronidazole." Br Med J 280 (1980): 647
  • "Product Information. Tindamax (tinidazole)." Presutti Laboratories Inc, Arlington Heights, IL.
  • "Product Information. Flagyl (metronidazole)." Searle, Skokie, IL.
  • Smith JA "Neutropenia associated with metronidazole therapy." Can Med Assoc J 123 (1980): 202
Bismuth subcitrate potassium, metronidazole, and tetracycline

Generic Name: bismuth subcitrate potassium / metronidazole / tetracycline

Brand Name: Pylera

Synonyms: Bismuth Subcitrate, Metronidazole, and Tetracycline